Choose CAPLYTA to help control symptoms with low rates of side effects in your adult patients with schizophrenia1
In clinical trials, the most common adverse reactions were somnolence/sedation (24%) and dry mouth (6%)1
Explore CAPLYTA Efficacy
See Safety & Tolerability
Request a Rep or Get Samples
Call now to request a rep or order samples of CAPLYTA.
CAPLYTA is manufactured for
Intra-Cellular Therapies, Inc.,
a biopharmaceutical company based on Nobel prize-winning science.